NOV 15, 2018 1:29 PM PST

Making Cancer Disappear?

WRITTEN BY: Nouran Amin

Neuroblastoma is one of the most common childhood cancers and the leading cause of cancer deaths among pediatric patients younger than 5. The cancer is frequently found in the adrenal glands on top of the kidneys. Despite intensive treatment regimens, survival rates are 50%.

Most recently, researchers investigating new treatments found a combination of two drugs that made the tumors ‘disappear’ in a mouse model.

"To study neuroblastoma in the laboratory, we use a genetically modified neuroblastoma mouse model that closely recapitulates clinical features of the disease, and these mice spontaneously develop neuroblastomas within weeks after birth,” says Professor Murray Norris, deputy director of the Children's Cancer Institute Australia for Medical Research.

The combination of drugs are CBL0137, which belong to curaxins—that attack the structure of cancer cells and the second is panobinostat. The FDA has approved panobinostat previously for Melanoma and is being tested for other cancers. Additionally, CBL0137 is currently undergoing the approval process for phase I clinical trials in adults.

Credit: University of Minnesota, ‘‘Dirty’ Mice May Be Better Models of Human Biology”

“We have found that when we combined CBL0137 and panobinostat to treat mice bearing neuroblastomas, the tumors disappeared and never came back during the entire experiment, whereas the tumors continued to grow in mice that received either no treatment or only single drug treatment. This is a highly significant finding as this drug combination is the most effective therapy that we have observed in this neuroblastoma mouse model. It is unusual to see this effect, especially in these mice where neuroblastoma develops within seven weeks of birth and is aggressive in nature. In fact, the CBL0137/panobinostat combination is more effective than any other current clinical chemotherapy combinations that our laboratory has tested in these mice,” says Prof. Norris.

To specifically detect the drug-induced changes in the tumors, researchers used RNA sequencing technology to examine how the drug combination was effective enough in eliminating the neuroblastoma.

"Our results suggest that these drugs work through two different mechanisms that offer a two-pronged attack. One of these mechanisms appears to be a direct attack on the cancer cells themselves, killing them by inhibiting DNA repair; then a second mechanism is involved in inducing a robust immune response. This is very exciting and will hopefully facilitate the clinical development of effective and non-toxic therapies for childhood cancer," explains Prof. Norris.

Researchers are hopeful to continue their investigation to show how the drugs activate immune responses, slow the growth of aggressive childhood leukemia, and to test CBL0137/panobinostat with other immunotherapy drugs in mice.

Source: ScienceDaily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 16, 2020
Cancer
JAN 16, 2020
FLASH proton therapy: faster and more effective
A new technique called FLASH proposes a new type of radiation therapy. The technique is composed of an ultra-high dose rate of radiotherapy and uses electr
JAN 17, 2020
Cancer
JAN 17, 2020
Could salt nanoparticles kill cancer?
Could salt be the key to killing cancer cells? A new study published in Advanced Materials reports success in using sodium chloride to destroy cancer cells
JAN 23, 2020
Cell & Molecular Biology
JAN 23, 2020
Scientists Engineer Venom-Producing Organoids
Snake venom is also a source of therapeutics, and a potential source of new medicines.
FEB 03, 2020
Drug Discovery & Development
FEB 03, 2020
HIV Viral Structures Improve Therapeutics
Researchers have recently discovered how a powerful class of HIV drugs bind to a key piece of HIV machinery. Their findings, for the first time, shows how
MAR 19, 2020
Drug Discovery & Development
MAR 19, 2020
Could a 1949 Malaria Drug Treat COVID-19?
In the race to halt the current coronavirus pandemic, scientists, health experts and even Elon Musk are considering chloroquine, a drug that has been used
MAR 20, 2020
Drug Discovery & Development
MAR 20, 2020
4 Potential Treatments for SARS-CoV-2 Currently Under Testing
Currently, no medicine nor vaccine has been approved as effective for the prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despi
Loading Comments...